Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$16.79 - $27.09 $443,272 - $715,203
-26,401 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$15.78 - $24.77 $416,607 - $653,952
26,401 New
26,401 $439,000
Q2 2020

Aug 12, 2020

SELL
$39.26 - $52.73 $7,498 - $10,071
-191 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$31.65 - $46.87 $6,045 - $8,952
191 New
191 $8,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.